Bank of America
TENX icon

Bank of America’s Tenax Therapeutics TENX Stock Holding History

Bank of America’s Portfolio TENX Stock Details TENX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q4 		– Sell
-11
Closed -$1.38M – 7952
2014
Q3 		$1.38M Sell
11
-9
-45% -$1.16M ﹤0.01% 3719
2014
Q2 		$2.65M Buy
+20
New +$3.08M ﹤0.01% 3113

Other funds holding TENX

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
VC
Vivo Capital Palo Alto, California $1.1B AUM 799.93% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
PA
Perceptive Advisors New York $6.66B AUM 360.84% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
IC
Ikarian Capital Dallas, Texas $928M AUM 596.14% 1-Year Est. Return
CS
Candriam SCA Strassen, Luxembourg, Luxembourg $22.2B AUM 58.34% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.89% 1-Year Est. Return
RI
RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return

Bank of America's TENX Position: Q2 2026 in Review

Bank of America increased its Tenax Therapeutics (TENX) stake by 635% in Q2 2026, buying an estimated $1.51M and bringing the position to 136,428 shares worth $1.99M. The position accounts for ﹤0.01% of the portfolio, ranked #4216.

Bank of America first reported a position in TENX in Q2 2014 and has held it in 11 quarters since. The position peaked at $2.94M in Q2 2014. 111 funds tracked by Wall St. Rank hold TENX as of Q2 2026.

  • Bank of America held 136,428 shares of Tenax Therapeutics worth $1.99M as of Q2 2026.
  • Bank of America bought 117,859 Tenax Therapeutics shares in Q2 2026, an estimated $1.51M.
  • Tenax Therapeutics made up ﹤0.01% of Bank of America's portfolio in Q2 2026, its #4216 holding.
  • Bank of America first reported a position in Tenax Therapeutics in Q2 2014 and has held it in 11 quarters since.
  • Bank of America's Tenax Therapeutics position peaked at $2.94M in Q2 2014.
  • 111 funds tracked by Wall St. Rank held Tenax Therapeutics as of Q2 2026.

Based on Bank of America's 13F filing for Q2 2026, filed 14 Aug 2026.